Eva Clerc

Tech/Deeptech Investor @Bpifrance

📍 France🔄 Updated September 2026💼 7 investments📅 4 years investing🗓 Last invested Jun 2025
VC🌍 France
7
Total investments
2
Early stage
2
Mid stage
1
Late stage
4y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor / Board Member
Jun 2025
We are pioneering a revolutionary approach to enhance global healthcare access by simplifing and improving the production of mRNA vaccines and therapies.
Investor / Board Member
Feb 2024
"Frédéric Bodin, Professor of Plastic Surgery, was taking over 200 photos a week and had no tools to sort and store them safely. In 2018, he went to a health innovation competition with the idea of creating an app to manage his medical photos. It was there that he met entrepreneur Matis Ringdal and engineer Vincent Marceddu. The prototype app they developed won several awards. "It all came together in 2019 when they founded the company and signed their first hospital contracts. Pixacare won the i-Lab contest, a government program that supports innovative startups. Concurrently, the company announced its first financing round of 2 million euros. In early 2023, the medical imaging library and wound management solutions received their CE marking for medical devices. Meanwhile, engineers have been developing AI technologies to measure and analyse chronic wounds. In 2023, Pixacare has been implemented in 20 hospitals across France and internationally. The application has registered over 50,000 patients and 250,000 photos. At the companys headquarters, the team now consists of 20 employees.
Investor / Board Member
Feb 2023
Fondée en 2015 par William Eldin, XXII sest imposée comme un leader incontournable de la vision par ordinateur en Europe. Avec une équipe dexperts, XXII conçoit, développe et commercialise CORE, une plateforme logicielle révolutionnaire facilitant le déploiement et la configuration dalgorithmes danalyse de flux vidéo. Lauréate du programme French Tech 2030 et future licorne française, XXII met sa plateforme CORE au service de nombreux secteurs, avec une présence sur plus de 500 sites.
Investor / Board Member
Jun 2022
Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer.
early stageBiotechnology
Investor / Board Member
Jun 2022
Le brossage complet des dents et des gencives, en un geste. Fabriquée en France 🇫🇷 Développée avec des dentistes et prouvée cliniquement ---- Complete tooth and gum brushing in one gesture. Made in France 🇫🇷 Developed with dentists and clinically proven
Investor / Board Member
May 2022
Sonio, a wholly-owned subsidiary of Samsung Medison Co., Ltd since 2024, is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. "Sonio AI-enhanced¹ software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI. ¹AI-enhancement is provided by FDA 510(k) cleared Sonio Detect product * Applicable to V1 only, Data enclosed at Sonio **See table 6 in the 510k summary: https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240406.pdf
Experience · 10 entries
All (10)
Investments (7)
Board (7)
2025
Investor / Board Member
Jun 2025
We are pioneering a revolutionary approach to enhance global healthcare access by simplifing and improving the production of mRNA vaccines and therapies.
2024
Investor / Board Member
Feb 2024
"Frédéric Bodin, Professor of Plastic Surgery, was taking over 200 photos a week and had no tools to sort and store them safely. In 2018, he went to a health innovation competition with the idea of creating an app to manage his medical photos. It was there that he met entrepreneur Matis Ringdal and engineer Vincent Marceddu. The prototype app they developed won several awards. "It all came together in 2019 when they founded the company and signed their first hospital contracts. Pixacare won the i-Lab contest, a government program that supports innovative startups. Concurrently, the company announced its first financing round of 2 million euros. In early 2023, the medical imaging library and wound management solutions received their CE marking for medical devices. Meanwhile, engineers have been developing AI technologies to measure and analyse chronic wounds. In 2023, Pixacare has been implemented in 20 hospitals across France and internationally. The application has registered over 50,000 patients and 250,000 photos. At the companys headquarters, the team now consists of 20 employees.
Investor / Board Member
Jan 2024
As Frances leading provider of cyber protection for critical systems, Seclab secures exchanges by simplifying interconnection architectures and eliminating the risks associated with software flaws in cybersecurity equipment. Its patented technology for electronically breaking all network and USB communication protocols enables the deployment of highly secure network architectures and remote control of cyber-physical systems. ANSSI-certified, our products are designed to secure the countrys most critical infrastructures. Our customers address the cybersecurity of their most sensitive assets with solutions that are simpler to implement and maintain than traditional approaches, while benefiting from the highest level of security available. Seclab is involved in the secure operation of the infrastructures and systems of most of Frances essential service operators.
VC Senior Investment Director
Jan 2024
L’équipe Deeptech Venture accompagne les jeunes pousses françaises issues de la recherche scientifique apportant des solutions innovantes de rupture technologique. Elle investit tôt, aux stades de capital amorçage (seed) et du capital risque (Serie A, B et C) avec la capacité d’accompagner dans la durée les entreprises avec plusieurs véhicules d’investissement généralistes (French Tech Seed, Deep Tech 2030, PSIM) et thématiques (Definvest, Fonds Innovation Défense). À travers ces dispositifs, Bpifrance Deeptech Venture permet aux innovations de rupture de franchir les phases critiques de développement et d’industrialisation, positionnant ainsi la France comme un leader européen de l’innovation scientifique et technologique. -------------------- The Deeptech Venture team supports French startups emerging from scientific research, providing innovative solutions through technological breakthroughs. They invest early, at the seed capital and venture capital stages (Series A, B, and C), with the ability to support companies over the long term through several generalist investment vehicles (French Tech Seed, Deep Tech 2030, PSIM) and thematic ones (Definvest, Defense Innovation Fund). Through these mechanisms, Bpifrance Deeptech Venture enables breakthrough innovations to navigate critical development and industrialization phases, positioning France as a European leader in scientific and technological innovation.
2023
Investor / Board Member
Feb 2023
Fondée en 2015 par William Eldin, XXII sest imposée comme un leader incontournable de la vision par ordinateur en Europe. Avec une équipe dexperts, XXII conçoit, développe et commercialise CORE, une plateforme logicielle révolutionnaire facilitant le déploiement et la configuration dalgorithmes danalyse de flux vidéo. Lauréate du programme French Tech 2030 et future licorne française, XXII met sa plateforme CORE au service de nombreux secteurs, avec une présence sur plus de 500 sites.
Show all 10 entries ↓
Investment activity
2022–2025 · 7 investments
20223202312024220251
Recent (last 2 years)Earlier